NCT03874052
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03874052
Title Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Jennifer Saultz
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Ohio State University Comprehensive Cancer Center SUSPENDED Columbus Ohio 43210 United States Details
OHSU Knight Cancer Institute RECRUITING Portland Oregon 97239 United States Details
UT Southwestern/Simmons Cancer Center-Dallas SUSPENDED Dallas Texas 75390 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field